Publicaciones en las que colabora con Sandra Gil Alonso (10)

2022

  1. Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

    Journal of Fungi, Vol. 8, Núm. 7

2019

  1. Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity

    Revista Iberoamericana de Micologia, Vol. 36, Núm. 1, pp. 24-29

  2. Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida Africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 183-188

  3. Therapeutic tools for oral candidiasis: Current and new antifungal drugs

    Medicina oral, patologia oral y cirugia bucal, Vol. 24, Núm. 2, pp. e172-e180

  4. Therapeutic tools for oral candidiasis: current and new antifungal drugs

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 24, Núm. 2, pp. 10

2016

  1. In vitro pharmacodynamic modelling of anidulafungin against Candida spp.

    International Journal of Antimicrobial Agents, Vol. 47, Núm. 3, pp. 178-183

  2. Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades

    Diagnostic Microbiology and Infectious Disease, Vol. 86, Núm. 2, pp. 172-177

2015

  1. Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves

    Diagnostic Microbiology and Infectious Disease, Vol. 82, Núm. 1, pp. 57-61

  2. In Vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 6, pp. 3615-3618

  3. Postantifungal effect of micafungin against the species complexes of Candida albicans and Candida parapsilosis

    PLoS ONE, Vol. 10, Núm. 7